EPAS1 and neoplasm: We first developed a tumour model in which HIF2A expression could be experimentally controlled by deriving a HIF2A knockout clone from 786-M1A cells (referred to as C-M1AHIF2A–/–) and reintroduced HIF2A in these cells using a doxycycline-dependent transgene (Extended Data Fig. 5a).